• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的可能治疗方法:综述。

Possible therapies of Parkinson's disease: A review.

机构信息

Allexcel, Inc., 1 Controls Drive, Shelton 06484, CT, United States.

Allexcel, Inc., 1 Controls Drive, Shelton 06484, CT, United States.

出版信息

J Clin Neurosci. 2020 May;75:1-4. doi: 10.1016/j.jocn.2020.03.024. Epub 2020 Apr 1.

DOI:10.1016/j.jocn.2020.03.024
PMID:32247740
Abstract

Parkinson's disease (PD) is a complex condition with a wide range of symptoms, like impaired movement, tremors, apathy and depression, and many other symptoms. The disease results from degeneration of dopaminergic neural cells. No cure at present but symptomatic some palliative treatments are available to slow down the disease progression. According to the Parkinson's Foundation every year in U.S., approximately 60,000 Americans diagnosed with PD. Nearly one million will be living with PD in the U.S. by 2020, which is more than the combined number of people diagnosed with multiple sclerosis, muscular dystrophy and Amyotrophic Lateral Sclerosis (ALS). There is no diagnostic test for PD, yet, but this article will review all kinds symptomatic and disease-modifying therapy.

摘要

帕金森病(PD)是一种复杂的疾病,具有广泛的症状,如运动障碍、震颤、冷漠和抑郁,以及许多其他症状。这种疾病是由多巴胺能神经元的退化引起的。目前尚无治愈方法,但有一些对症的姑息治疗可以减缓疾病的进展。根据帕金森基金会的数据,美国每年约有 6 万人被诊断出患有 PD。到 2020 年,将有近 100 万人患有 PD,这超过了多发性硬化症、肌肉萎缩症和肌萎缩性侧索硬化症(ALS)患者的总和。目前还没有针对 PD 的诊断测试,但本文将回顾各种对症和疾病修饰治疗。

相似文献

1
Possible therapies of Parkinson's disease: A review.帕金森病的可能治疗方法:综述。
J Clin Neurosci. 2020 May;75:1-4. doi: 10.1016/j.jocn.2020.03.024. Epub 2020 Apr 1.
2
A review of possible therapies for Parkinson's disease.帕金森病可能疗法的综述。
J Clin Neurosci. 2020 Jun;76:1-4. doi: 10.1016/j.jocn.2020.03.047. Epub 2020 Apr 9.
3
Polyphenols and Stem Cells for Neuroregeneration in Parkinson's Disease and Amyotrophic Lateral Sclerosis.多酚和干细胞在帕金森病和肌萎缩侧索硬化症的神经再生中的作用。
Curr Pharm Des. 2022;28(10):806-828. doi: 10.2174/1381612827666211115154450.
4
Gene-based therapies in Parkinson's disease.帕金森病的基因疗法。
Neurotherapeutics. 2014 Jan;11(1):60-7. doi: 10.1007/s13311-013-0233-2.
5
Does levodopa slow or hasten the rate of progression of Parkinson's disease?左旋多巴会减缓还是加速帕金森病的进展速度?
J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. doi: 10.1007/s00415-005-4008-5.
6
How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's Disease.如何使用新的欧洲神经病学学会/运动障碍学会欧洲分会帕金森病侵入性治疗指南。
Mov Disord Clin Pract. 2024 Mar;11(3):209-219. doi: 10.1002/mdc3.13962. Epub 2024 Jan 12.
7
Parkinson's disease treatment: past, present, and future.帕金森病的治疗:过去、现在和未来。
J Neural Transm (Vienna). 2020 May;127(5):785-791. doi: 10.1007/s00702-020-02167-1. Epub 2020 Mar 14.
8
Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson's Disease and Amyotrophic Lateral Sclerosis.布赖特-法恩-施瓦茨病:帕金森病与肌萎缩侧索硬化症的一种独特共病情况。
Case Rep Neurol. 2023 Sep 21;15(1):207-214. doi: 10.1159/000532092. eCollection 2023 Jan-Dec.
9
Parkinson's disease: the case for novel treatment strategies.帕金森病:新型治疗策略的情况
Exp Neurol. 1997 Mar;144(1):2-3. doi: 10.1006/exnr.1996.6378.
10
New pharmacological options for treating advanced Parkinson's disease.治疗晚期帕金森病的新药理学选择。
Clin Ther. 2013 Oct;35(10):1640-52. doi: 10.1016/j.clinthera.2013.08.011. Epub 2013 Sep 5.

引用本文的文献

1
Terazosin Analogs Targeting Pgk1 as Neuroprotective Agents: Design, Synthesis, and Evaluation.靶向磷酸甘油酸激酶1的特拉唑嗪类似物作为神经保护剂:设计、合成与评价
Front Chem. 2022 Jul 26;10:906974. doi: 10.3389/fchem.2022.906974. eCollection 2022.
2
Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole Scaffold.基于 5-(4-吡啶基)-1,2,4-三唑骨架的神经保护剂的发现。
ACS Chem Neurosci. 2022 Mar 2;13(5):581-586. doi: 10.1021/acschemneuro.1c00849. Epub 2022 Feb 18.
3
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease.
小分子抑制剂的合理设计可抑制α-突触核蛋白淀粉样聚集,用于治疗帕金森病。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1727-1735. doi: 10.1080/14756366.2020.1816999.